casein kinase 1 delta inhibitors (Merck & Co)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecasein kinase 1 delta inhibitors (Merck & Co)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 modulatorsCasein kinase I isoform delta inhibitors
TargetsCasein kinase I isoform deltaCatenin beta 1
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A